Related references
Note: Only part of the references are listed.Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion
Nicole E. Scharping et al.
NATURE IMMUNOLOGY (2021)
Low-dose decitabine priming endows CAR T cells with enhanced and persistent antitumour potential via epigenetic reprogramming
Yao Wang et al.
NATURE COMMUNICATIONS (2021)
Targeting EZH2 Enhances Antigen Presentation, Antitumor Immunity, and Circumvents Anti-PD-1 Resistance in Head and Neck Cancer
Liye Zhou et al.
CLINICAL CANCER RESEARCH (2020)
Impaired T cell proliferation by ex vivo BET-inhibition impedes adoptive immunotherapy in a murine melanoma model
Jonathan Chee et al.
EPIGENETICS (2020)
The emerging role of epigenetic therapeutics in immuno-oncology
Michael J. Topper et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
IMMUNITY, HYPOXIA, AND METABOLISM-THE MENAGE A TROIS OF CANCER: IMPLICATIONS FOR IMMUNOTHERAPY
Carla Riera-Domingo et al.
PHYSIOLOGICAL REVIEWS (2020)
A cellular antidote to specifically deplete anti-CD19 chimeric antigen receptor-positive cells
Marco Ruella et al.
BLOOD (2020)
Methionine Metabolism Shapes T Helper Cell Responses through Regulation of Epigenetic Reprogramming
Dominic G. Roy et al.
CELL METABOLISM (2020)
Modulation of SRSF2 expression reverses the exhaustion of TILs via the epigenetic regulation of immune checkpoint molecules
Ziqiang Wang et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
The phosphatase PAC1 acts as a T cell suppressor and attenuates host antitumor immunity
Dan Lu et al.
NATURE IMMUNOLOGY (2020)
Developmental plasticity allows outside-in immune responses by resident memory T cells
Raissa Fonseca et al.
NATURE IMMUNOLOGY (2020)
Decitabine Augments Chemotherapy-Induced PD-L1 Upregulation for PD-L1 Blockade in Colorectal Cancer
Kevin Chih-Yang Huang et al.
CANCERS (2020)
Developmental Relationships of Four Exhausted CD8+ T Cell Subsets Reveals Underlying Transcriptional and Epigenetic Landscape Control Mechanisms
Jean-Christophe Beltra et al.
IMMUNITY (2020)
Divergent Effects of Dnmt3a and Tet2 Mutations on Hematopoietic Progenitor Cell Fitness
Elizabeth L. Ostrander et al.
STEM CELL REPORTS (2020)
Targeting Nuclear LSD1 to Reprogram Cancer Cells and Reinvigorate Exhausted T Cells via a Novel LSD1-EOMES Switch
Wen Juan Tu et al.
FRONTIERS IN IMMUNOLOGY (2020)
An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors
Kirsty Taylor et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
RORα Regulates Cholesterol Metabolism of CD8+ T Cells for Anticancer Immunity
In Kyu Lee et al.
CANCERS (2020)
DNA methyltransferases in hematological malignancies
Nguyet-Minh Hoang et al.
JOURNAL OF GENETICS AND GENOMICS (2020)
Epigenetic Control of Cdkn2a.Arf Protects Tumor-Infiltrating Lymphocytes from Metabolic Exhaustion
Brian Koss et al.
CANCER RESEARCH (2020)
Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen
Santosha A. Vardhana et al.
NATURE IMMUNOLOGY (2020)
The histone methyltransferase DOT1L prevents antigen-independent differentiation and safeguards epigenetic identity of CD8+ T cells
Eliza Mari Kwesi-Maliepaard et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Rewriting History: Epigenetic Reprogramming of CD8+T Cell Differentiation to Enhance Immunotherapy
Caitlin C. Zebley et al.
TRENDS IN IMMUNOLOGY (2020)
Cancer SLC43A2 alters T cell methionine metabolism and histone methylation
Yingjie Bian et al.
NATURE (2020)
Metabolic conditioning of CD8+ effector T cells for adoptive cell therapy
Ramon I. Klein Geltink et al.
NATURE METABOLISM (2020)
Low-dose decitabine enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by re-modulating the tumor microenvironment
Ganjun Yu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2019)
Sequentially inducible mouse models reveal that Npm1 mutation causes malignant transformation of Dnmt3a-mutant clonal hematopoiesis
Matthew A. Loberg et al.
LEUKEMIA (2019)
NR4A transcription factors limit CAR T cell function in solid tumours
Joyce Chen et al.
NATURE (2019)
Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade
Brian C. Miller et al.
NATURE IMMUNOLOGY (2019)
Targeting epigenetic modifications in cancer therapy: erasing the roadmap to cancer
Helai P. Mohammad et al.
NATURE MEDICINE (2019)
Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate
Abhishek A. Chakraborty et al.
SCIENCE (2019)
Hypoxia induces rapid changes to histone methylation and reprograms chromatin
Michael Batie et al.
SCIENCE (2019)
T cell stemness and dysfunction in tumors are triggered by a common mechanism
Suman Kumar Vodnala et al.
SCIENCE (2019)
Lactate: A Metabolic Driver in the Tumour Landscape
Luigi Ippolito et al.
TRENDS IN BIOCHEMICAL SCIENCES (2019)
Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition
Daisuke Ennishi et al.
CANCER DISCOVERY (2019)
IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory Phenotype
Darya Alizadeh et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Mitochondrial superoxide disrupts the metabolic and epigenetic landscape of CD4+ and CD8+ T-lymphocytes
C. M. Moshfegh et al.
REDOX BIOLOGY (2019)
Optimization of 4-1BB antibody for cancer immunotherapy by balancing agonistic strength with FcγR affinity
Xinyue Qi et al.
NATURE COMMUNICATIONS (2019)
Acetate Promotes T Cell Effector Function during Glucose Restriction
Jing Qiu et al.
CELL REPORTS (2019)
Antigen receptor control of methionine metabolism in T cells
Linda V. Sinclair et al.
ELIFE (2019)
TOX is a critical regulator of tumour-specific T cell differentiation
Andrew C. Scott et al.
NATURE (2019)
Dietary methionine influences therapy in mouse cancer models and alters human metabolism
Xia Gao et al.
NATURE (2019)
Advances in epigenetics link genetics to the environment and disease
Giacomo Cavalli et al.
NATURE (2019)
TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion
Omar Khan et al.
NATURE (2019)
Single-cell RNA-seq reveals TOX as a key regulator of CD8+ T cell persistence in chronic infection
Chen Yao et al.
NATURE IMMUNOLOGY (2019)
TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8+ T cell exhaustion
Hyungseok Seo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
miR-155 harnesses Phf19 to potentiate cancer immunotherapy through epigenetic reprogramming of CD8+ T cell fate
Yun Ji et al.
NATURE COMMUNICATIONS (2019)
Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells
Tessa Knox et al.
SCIENTIFIC REPORTS (2019)
Degradation of D-2-hydroxyglutarate in the presence of isocitrate dehydrogenase mutations
Raffaela S. Berger et al.
SCIENTIFIC REPORTS (2019)
Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function
Selena Vigano et al.
FRONTIERS IN IMMUNOLOGY (2019)
Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation Antigen
Marijke Timmers et al.
FRONTIERS IN IMMUNOLOGY (2019)
An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer
Marian L. Burr et al.
CANCER CELL (2019)
Anti-CAR-engineered T cells for epitope-based elimination of autologous CAR T cells
Stefanie Koristka et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
The Transcription Factor Bhlhe40 Programs Mitochondria! Regulation of Resident CD8+ T Cell Fitness and Functionality
Chaofan Li et al.
IMMUNITY (2019)
Non-catalytic Roles of Tet2 Are Essential to Regulate Hematopoietic Stem and Progenitor Cell Homeostasis
Kyoko Ito et al.
CELL REPORTS (2019)
Reactive Oxygen Species in the Tumor Microenvironment: An Overview
Frank Weinberg et al.
CANCERS (2019)
Metabolic Profiling Using Stable Isotope Tracing Reveals Distinct Patterns of Glucose Utilization by Physiologically Activated CD8+ T Cells
Eric H. Ma et al.
IMMUNITY (2019)
Metabolic regulation of gene expression by histone lactylation
Di Zhang et al.
NATURE (2019)
Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion
Robert D. Leone et al.
SCIENCE (2019)
Coordinative metabolism of glutamine carbon and nitrogen in proliferating cancer cells under hypoxia
Yuanyuan Wang et al.
NATURE COMMUNICATIONS (2019)
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Jonathan J. Havel et al.
NATURE REVIEWS CANCER (2019)
Rational cotargeting of HDAC6 and BET proteins yields synergistic antimyeloma activity
Jennifer S. Carew et al.
BLOOD ADVANCES (2019)
Distinct epigenetic features of tumor-reactive CD8+T cells in colorectal cancer patients revealed by genome-wide DNA methylation analysis
Rui Yang et al.
GENOME BIOLOGY (2019)
Metabolic reprogramming of human CD8+ memory T cells through loss of SIRT1
Mark Y. Jeng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
CD137 (4-1BB) Costimulation Modifies DNA Methylation in CD8+ T Cell-Relevant Genes
M. Angela Aznar et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment
Chiara Riganti et al.
ONCOIMMUNOLOGY (2018)
Tumor-Repopulating Cells Induce PD-1 Expression in CD8(+) T Cells by Transferring Kynurenine and AhR Activation
Yuying Liu et al.
CANCER CELL (2018)
D-2-Hydroxyglutarate Is an Intercellular Mediator in IDH-Mutant Gliomas Inhibiting Complement and T Cells
Lingjun Zhang et al.
CLINICAL CANCER RESEARCH (2018)
RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2
Mengnuo Chen et al.
HEPATOLOGY (2018)
4-1BB costimulation induces T cell mitochondrial function and biogenesis enabling cancer immunotherapeutic responses
Ashley V. Menk et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Metabolic Barriers to T Cell Function in Tumors
Ayaka Sugiura et al.
JOURNAL OF IMMUNOLOGY (2018)
Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate
Lukas Bunse et al.
NATURE MEDICINE (2018)
The Key Role of Epigenetics in Human Disease Prevention and Mitigation
Andrew P. Feinberg
NEW ENGLAND JOURNAL OF MEDICINE (2018)
DOT1L inhibition attenuates graft-versus-host disease by allogeneic T cells in adoptive immunotherapy models
Yuki Kagoya et al.
NATURE COMMUNICATIONS (2018)
Carnitine Palmitoyltransferase 1A Has a Lysine Succinyltransferase Activity
Kiran Kurmi et al.
CELL REPORTS (2018)
Loss of Dnmt3a Immortalizes Hematopoietic Stem Cells In Vivo
Mira Jeong et al.
CELL REPORTS (2018)
Modulation of EZH2 expression in T cells improves efficacy of anti-CTLA-4 therapy
Sangeeta Goswami et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells
Joseph A. Fraietta et al.
NATURE (2018)
BET Bromodomain Inhibition Cooperates with PD-1 Blockade to Facilitate Antitumor Response in Kras-Mutant Non-Small Cell Lung Cancer
Dennis O. Adeegbe et al.
CANCER IMMUNOLOGY RESEARCH (2018)
KAT2A coupled with the α-KGDH complex acts as a histone H3 succinyltransferase
Yugang Wang et al.
NATURE (2017)
Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism
Youdong Pan et al.
NATURE (2017)
The immune contexture in cancer prognosis and treatment
Wolf H. Fridman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Dual-specificity phosphatase 5 controls the localized inhibition, propagation, and transforming potential of ERK signaling
Andrew M. Kidger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Synergistic Immunostimulatory Effects and Therapeutic Benefit of Combined Histone Deacetylase and Bromodomain Inhibition in Non-Small Cell Lung Cancer
Dennis O. Adeegbe et al.
CANCER DISCOVERY (2017)
The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy
Daniel Zingg et al.
CELL REPORTS (2017)
BET-Bromodomain Inhibitors Engage the Host Immune System and Regulate Expression of the Immune Checkpoint Ligand PD-L1
Simon J. Hogg et al.
CELL REPORTS (2017)
Increased IFNγ+ T Cells Are Responsible for the Clinical Responses of Low-Dose DNA-Demethylating Agent Decitabine Antitumor Therapy
Xiang Li et al.
CLINICAL CANCER RESEARCH (2017)
Enhancing CD8+ T Cell Fatty Acid Catabolism within a Metabolically Challenging Tumor Microenvironment Increases the Efficacy of Melanoma Immunotherapy
Ying Zhang et al.
CANCER CELL (2017)
Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression
Luisa Cimmino et al.
CELL (2017)
T cells lacking HDAC11 have increased effector functions and mediate enhanced alloreactivity in a murine model
David M. Woods et al.
BLOOD (2017)
De Novo Epigenetic Programs Inhibit PD-1 Blockade-Mediated T Cell Rejuvenation
Hazem E. Ghoneim et al.
CELL (2017)
Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma
Peter J. Siska et al.
JCI INSIGHT (2017)
The Histone Methyltransferase DOT1L Promotes Neuroblastoma by Regulating Gene Transcription
Matthew Wong et al.
CANCER RESEARCH (2017)
Lineage relationship of CD8+ T cell subsets is revealed by progressive changes in the epigenetic landscape
Joseph G. Crompton et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2016)
Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction
Ende Zhao et al.
NATURE IMMUNOLOGY (2016)
DUSP10 regulates intestinal epithelial cell growth and colorectal tumorigenesis
C. W. Png et al.
ONCOGENE (2016)
T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells
Ilaria Marigo et al.
CANCER CELL (2016)
L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity
Roger Geiger et al.
CELL (2016)
AMPK/Snf1 signaling regulates histone acetylation: Impact on gene expression and epigenetic functions
Antero Salminen et al.
CELLULAR SIGNALLING (2016)
HDAC Inhibitors Enhance T-Cell Chemokine Expression and Augment Response to PD-1 Immunotherapy in Lung Adenocarcinoma
Hong Zheng et al.
CLINICAL CANCER RESEARCH (2016)
Metabolic control of methylation and acetylation
Xiaoyang Su et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2016)
Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8+ T Cell Exhaustion
Bertram Bengsch et al.
IMMUNITY (2016)
BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models
Yuki Kagoya et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Tumour hypoxia causes DNA hyper-methylation by reducing TET activity
Bernard Thienpont et al.
NATURE (2016)
Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism
Wei Yang et al.
NATURE (2016)
Ionic immune suppression within the tumour microenvironment limits T cell effector function
Robert Eil et al.
NATURE (2016)
S-2-hydroxyglutarate regulates CD8+ T-lymphocyte fate
Petros A. Tyrakis et al.
NATURE (2016)
Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism
Min Peng et al.
SCIENCE (2016)
Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade
Kristen E. Pauken et al.
SCIENCE (2016)
Lipids Reprogram Metabolism to Become a Major Carbon Source for Histone Acetylation
Eoin McDonnell et al.
CELL REPORTS (2016)
Starved and Asphyxiated: How Can CD8+ T Cells within a Tumor Microenvironment Prevent Tumor Progression
Ying Zhang et al.
FRONTIERS IN IMMUNOLOGY (2016)
Regulation of T cell signalling by membrane lipids
Wei Wu et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chih-Hao Chang et al.
CELL (2015)
Hypoxia Induces Production of L-2-Hydroxyglutarate
Andrew M. Intlekofer et al.
CELL METABOLISM (2015)
Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected
Douglas Marvel et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
CRISPR/Cas9 somatic multiplex-mutagenesis for high-throughput functional cancer genomics in mice
Julia Weber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Decitabine Enhances Lymphocyte Migration and Function and Synergizes with CTLA-4 Blockade in a Murine Ovarian Cancer Model
Lei Wang et al.
CANCER IMMUNOLOGY RESEARCH (2015)
HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade
David M. Woods et al.
CANCER IMMUNOLOGY RESEARCH (2015)
miR-155 augments CD8+ T-cell antitumor activity in lymphoreplete hosts by enhancing responsiveness to homeostatic γc cytokines
Yun Ji et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
T-bet and Eomes Are Differentially Linked to the Exhausted Phenotype of CD8+T Cells in HIV Infection
Marcus Buggert et al.
PLOS PATHOGENS (2014)
The histone deacetylase inhibitor, LBH589, promotes the systemic cytokine and effector responses of adoptively transferred CD8+ T cells
Dominique N. Lisiero et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2014)
Nitric Oxide Modifies Global Histone Methylation by Inhibiting Jumonji C Domain-containing Demethylases
Jason R. Hickok et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Epigenetic Regulation of Autophagy by the Methyltransferase G9a
Amaia Artal-Martinez de Narvajas et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
IDH mutation impairs histone demethylation and results in a block to cell differentiation
Chao Lu et al.
NATURE (2012)
Enhanced Antitumor Activity Induced by Adoptive T-Cell Transfer and Adjunctive Use of the Histone Deacetylase Inhibitor LAQ824
Dan D. Vo et al.
CANCER RESEARCH (2009)
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Lenny Dang et al.
NATURE (2009)
ATP-Citrate Lyase Links Cellular Metabolism to Histone Acetylation
Kathryn E. Wellen et al.
SCIENCE (2009)
Inhibitory B7-family molecules in the tumour microenvironment
Weiping Zou et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Engineered human tmpk/AZT as a novel enzyme/prodrug axis for suicide gene therapy
Takeya Sato et al.
MOLECULAR THERAPY (2007)
Pyruvate protects mitochondria from oxidative stress in human neuroblastoma SK-N-SH cells
Xiaofei Wang et al.
BRAIN RESEARCH (2007)
An inducible caspase 9 safety switch for T-cell therapy
KC Straathof et al.
BLOOD (2005)
The PAC-1 dual specificity phosphatase predicts poor outcome in serous ovarian carcinoma
V Givant-Horwitz et al.
GYNECOLOGIC ONCOLOGY (2004)
Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity
TJ Curiel et al.
NATURE MEDICINE (2003)
Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft
P Tiberghien et al.
BLOOD (2001)
Share Paper
